ICD-10 Code for Myopathy
The ICD-10-CM code for myopathy is G72.9 — Myopathy, unspecified. This is the code the Alphabetic Index gives for myopathy with no further qualifier, valid for FY2027 (October 1, 2026 – September 30, 2027).
BillableUnspecified
G72.9 is billable but unspecified. If the documentation names a type, site or cause, one of the more specific codes below is likely expected.
Which myopathy code should you use?
The Alphabetic Index lists 43 codes under Myopathy. Which one applies depends on the qualifier documented in the record — the type, site, cause, or associated condition. Find the qualifier below, then verify the code in the Tabular List before using it.
By type
| alcoholic | G72.1 | Alcoholic myopathy | |
| benign congenital | G71.20 | Congenital myopathy, unspecified | |
| central core | G71.29 | Other congenital myopathy | |
| centronuclear | G71.228 | Other centronuclear myopathy | |
| congenital | G71.20 | Congenital myopathy, unspecified | |
| critical illness | G72.81 | Critical illness myopathy | |
| distal | G71.09 | Other specified muscular dystrophies | |
| drug-induced | G72.0 | Drug-induced myopathy | |
| endocrine NEC | E34.9 | Endocrine disorder, unspecified | |
| extraocular muscles | H05.82 | Myopathy of extraocular muscles | not billable |
| facioscapulohumeral | G71.02 | Facioscapulohumeral muscular dystrophy | |
| hereditary | G71.9 | Primary disorder of muscle, unspecified | |
| hyaline body | G71.29 | Other congenital myopathy | |
| immune NEC | G72.49 | Other inflammatory and immune myopathies, not elsewhere classified | |
| inflammatory NEC | G72.49 | Other inflammatory and immune myopathies, not elsewhere classified | |
| intensive care | G72.81 | Critical illness myopathy | |
| mitochondrial NEC | G71.3 | Mitochondrial myopathy, not elsewhere classified | |
| Miyoshi, type 3 | G71.035 | Limb girdle muscular dystrophy due to anoctamin-5 dysfunction | |
| myosin storage | G71.29 | Other congenital myopathy | |
| mytonic, proximal | G71.11 | Myotonic muscular dystrophy | |
| myotubular | G71.220 | X-linked myotubular myopathy | |
| nemaline | G71.21 | Nemaline myopathy | |
| ocular | G71.09 | Other specified muscular dystrophies | |
| oculopharyngeal | G71.09 | Other specified muscular dystrophies | |
| of critical illness | G72.81 | Critical illness myopathy | |
| primary | G71.9 | Primary disorder of muscle, unspecified | |
| progressive NEC | G72.89 | Other specified myopathies | |
| proximal myotonic | G71.11 | Myotonic muscular dystrophy | |
| rod | G71.21 | Nemaline myopathy | |
| scapulohumeral | G71.02 | Facioscapulohumeral muscular dystrophy | |
| specified NEC | G72.89 | Other specified myopathies | |
| toxic | G72.2 | Myopathy due to other toxic agents |
Myopathy centronuclear
Myopathy hereditary
| specified NEC | G71.8 | Other primary disorders of muscles |
Myopathy in
| Addison's disease | E27.1 | Primary adrenocortical insufficiency | |
| alcohol | G72.1 | Alcoholic myopathy | |
| amyloidosis | E85.0 | Non-neuropathic heredofamilial amyloidosis | |
| cretinism | E00.9 | Congenital iodine-deficiency syndrome, unspecified | |
| Cushing's syndrome | E24.9 | Cushing's syndrome, unspecified | |
| drugs | G72.0 | Drug-induced myopathy | |
| endocrine disease NEC | E34.9 | Endocrine disorder, unspecified | |
| giant cell arteritis | M31.6 | Other giant cell arteritis | |
| glycogen storage disease | E74.00 | Glycogen storage disease, unspecified | |
| hyperadrenocorticism | E24.9 | Cushing's syndrome, unspecified | |
| hyperparathyroidism NEC | E21.3 | Hyperparathyroidism, unspecified | |
| hypoparathyroidism | E20.9 | Hypoparathyroidism, unspecified | |
| hypopituitarism | E23.0 | Hypopituitarism | |
| hypothyroidism | E03.9 | Hypothyroidism, unspecified | |
| infectious disease NEC | B99 | Other and unspecified infectious diseases | not billable |
| lipid storage disease | E75.6 | Lipid storage disorder, unspecified | |
| metabolic disease NEC | E88.9 | Metabolic disorder, unspecified | |
| myxedema | E03.9 | Hypothyroidism, unspecified | |
| parasitic disease NEC | B89 | Unspecified parasitic disease | |
| polyarteritis nodosa | M30.0 | Polyarteritis nodosa | |
| sarcoidosis | D86.87 | Sarcoid myositis | |
| scleroderma | M34.82 | Systemic sclerosis with myopathy | |
| sicca syndrome | M35.03 | Sjogren syndrome with myopathy | |
| Sjögren's syndrome | M35.03 | Sjogren syndrome with myopathy | |
| systemic lupus erythematosus | M32.19 | Other organ or system involvement in systemic lupus erythematosus | |
| thyrotoxicosis | E05.90 | Thyrotoxicosis, unspecified without thyrotoxic crisis or storm | |
| toxic agent NEC | G72.2 | Myopathy due to other toxic agents | |
| thyrotoxicosis › with thyroid storm | E05.91 | Thyrotoxicosis, unspecified with thyrotoxic crisis or storm |
Myopathy myotubular
| X-linked | G71.220 | X-linked myotubular myopathy |
Myopathy primary
| specified NEC | G71.8 | Other primary disorders of muscles |
Index terms and codes are reproduced from the official ICD-10-CM FY2027 release. The Alphabetic Index is a finding aid — a code must always be verified in the Tabular List before it is reported. Data sources